GLP1R and diabetes mellitus: Alternatively, could ACH have been elicited by the use of incretin-based anti-diabetes medications, namely glucagon-like peptide-1 receptor agonists (GLP-1Ra), subsequently contributing to the development of glucagon-producing NET?